W E Fann, C R Lake, C J Gerber, G M McKenzie. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Acetylcholine/physiologyAgedBinding SitesBrain/metabolismDopamine/physiologyFemaleHumansHyperkinesis/chemically inducedHyperkinesis/drug therapyHyperkinesis/etiologyInjections, IntravenousMaleMiddle AgedMovement Disorders/chemically inducedMovement Disorders/drug therapyMovement Disorders/etiologyPhysostigmine/administration & dosagePhysostigmine/therapeutic useSchizophrenia/drug therapySynaptic TransmissionTime FactorsTranquilizing Agents/adverse effects
Substances: See more » Tranquilizing AgentsPhysostigmineAcetylcholineDopamine
Year: 1974 PMID: 4367406 DOI: 10.1007/bf00437417
Source DB: PubMed Journal: Psychopharmacologia